1. Home
  2. XELB vs NCEL Comparison

XELB vs NCEL Comparison

Compare XELB & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$2.14

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.66

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XELB
NCEL
Founded
2011
2008
Country
United States
Switzerland
Employees
N/A
11
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
10.3M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
XELB
NCEL
Price
$2.14
$2.66
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
47.6K
17.1K
Earning Date
04-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
48.37
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$83.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$1.83
52 Week High
$4.20
$4.70

Technical Indicators

Market Signals
Indicator
XELB
NCEL
Relative Strength Index (RSI) 65.99 58.05
Support Level $1.29 $2.50
Resistance Level $2.23 $3.16
Average True Range (ATR) 0.21 0.18
MACD 0.07 0.06
Stochastic Oscillator 96.63 98.81

Price Performance

Historical Comparison
XELB
NCEL

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: